PEGUNIGALSIDASE ALFA

PEGUNIGALSIDASE ALFA was reported 377 times

PEGUNIGALSIDASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINE OUTPUT FLUCTUATION 1 0.0312
1 TRAUMATIC INTRACRANIAL HAEMATOMA 1 0.0312
2 BASILAR ARTERY ANEURYSM 1 0.0303
3 GLOBOTRIAOSYLCERAMIDE INCREASED 2 0.0190
4 VERTEBROBASILAR STROKE 1 0.0182
5 GLOBOTRIAOSYLSPHINGOSINE INCREASED 3 0.0153
6 ANGIOKERATOMA 1 0.0118
7 VASCULAR ACCESS SITE EXTRAVASATION 1 0.0115
8 WEIGHT 1 0.0106
9 PATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0075
10 PERSEVERATION 1 0.0054
11 HYPOHIDROSIS 2 0.0040
12 INCISION SITE DISCHARGE 1 0.0040
13 GRAFT THROMBOSIS 1 0.0038
14 INCISION SITE SWELLING 1 0.0033
15 CORNEA VERTICILLATA 1 0.0033
16 ARRHYTHMIC STORM 1 0.0030
17 TRICUSPID VALVE DISEASE 1 0.0025
18 SINONASAL OBSTRUCTION 1 0.0025
19 TRANSPLANTATION COMPLICATION 1 0.0024
20 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
21 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1 0.0019
22 INADEQUATE DIET 1 0.0019
23 OESOPHAGEAL FOOD IMPACTION 1 0.0018
24 TOXIC SHOCK SYNDROME 1 0.0016
25 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
26 STASIS DERMATITIS 1 0.0015
27 LIMB CRUSHING INJURY 1 0.0013
28 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
29 CRANIOFACIAL FRACTURE 1 0.0012
30 FOLLICULAR LYMPHOMA 1 0.0011
31 VASCULAR PAIN 1 0.0010
32 DISCOLOURED VOMIT 1 0.0010
33 RENAL TRANSPLANT FAILURE 1 0.0010
34 CARDIAC DISCOMFORT 2 0.0010
35 SYSTOLIC DYSFUNCTION 1 0.0009
36 STRESS AT WORK 1 0.0009
37 FRACTURED SACRUM 1 0.0008
38 AORTIC VALVE REPLACEMENT 1 0.0008
39 MALLORY-WEISS SYNDROME 1 0.0008
40 NOCTURNAL DYSPNOEA 1 0.0008
41 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
42 MENTAL FATIGUE 1 0.0007
43 BLOOD PRESSURE IMMEASURABLE 1 0.0007
44 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
45 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
46 AORTIC VALVE DISEASE 1 0.0006
47 SKULL FRACTURE 1 0.0006
48 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
49 SUDDEN HEARING LOSS 1 0.0005
50 INFUSION SITE EXTRAVASATION 3 0.0005
51 INFUSION SITE BRUISING 1 0.0005
52 DISLOCATION OF VERTEBRA 1 0.0004
53 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
54 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
55 VENTRICULAR HYPERTROPHY 1 0.0004
56 PERIORBITAL OEDEMA 2 0.0004
57 BRAIN FOG 6 0.0004
58 THROAT TIGHTNESS 10 0.0004
59 EOSINOPHILIC OESOPHAGITIS 1 0.0004
60 CEREBRAL THROMBOSIS 1 0.0004
61 DYSPNOEA AT REST 1 0.0003
62 ENERGY INCREASED 2 0.0003
63 CRANIOCEREBRAL INJURY 1 0.0003
64 LARYNGEAL OEDEMA 2 0.0003
65 BLOOD CREATININE DECREASED 1 0.0003
66 INFUSION SITE PRURITUS 1 0.0003
67 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
68 ILL-DEFINED DISORDER 19 0.0003
69 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
70 INFUSION SITE HAEMORRHAGE 1 0.0003
71 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
72 SINUS CONGESTION 4 0.0003
73 CLOSTRIDIAL INFECTION 1 0.0003
74 FACIAL PARESIS 1 0.0003
75 RENAL TRANSPLANT 1 0.0003
76 SNEEZING 6 0.0003
77 PROTEIN TOTAL DECREASED 1 0.0003
78 PRODUCT STORAGE ISSUE 1 0.0003
79 CLAVICLE FRACTURE 1 0.0003
80 THYROID MASS 1 0.0003
81 INFUSION RELATED REACTION 17 0.0003
82 LEG AMPUTATION 1 0.0002
83 BUNDLE BRANCH BLOCK LEFT 1 0.0002
84 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
85 HEPATIC LESION 1 0.0002
86 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
87 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
88 KIDNEY TRANSPLANT REJECTION 1 0.0002
89 PRESCRIBED OVERDOSE 4 0.0002
90 HYPERVOLAEMIA 1 0.0002
91 LIGAMENT SPRAIN 2 0.0002
92 INFLAMMATORY MARKER INCREASED 1 0.0002
93 HYPERNATRAEMIA 1 0.0002
94 VEIN DISORDER 1 0.0002
95 ERYSIPELAS 1 0.0002
96 DRUG TOLERANCE 1 0.0002
97 INSURANCE ISSUE 3 0.0002
98 TRISMUS 1 0.0002
99 DEAFNESS 5 0.0002
100 STREPTOCOCCAL INFECTION 1 0.0002
101 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
102 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
103 SINUS HEADACHE 1 0.0002
104 NEURALGIA 4 0.0002
105 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
106 MUSCLE ATROPHY 2 0.0002
107 THROAT IRRITATION 7 0.0002
108 INFUSION SITE PAIN 2 0.0002
109 PRODUCT PREPARATION ISSUE 1 0.0002
110 APPETITE DISORDER 1 0.0002
111 SKIN MASS 1 0.0001
112 LYMPHOEDEMA 1 0.0001
113 BURNING SENSATION 10 0.0001
114 HAND FRACTURE 1 0.0001
115 PRODUCT SUPPLY ISSUE 1 0.0001
116 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
117 ORAL DISORDER 1 0.0001
118 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
119 TROPONIN INCREASED 1 0.0001
120 EYE PRURITUS 4 0.0001
121 SENSATION OF FOREIGN BODY 1 0.0001
122 INFUSION SITE ERYTHEMA 1 0.0001
123 MUSCLE STRAIN 1 0.0001
124 SKIN SWELLING 1 0.0001
125 HEART RATE DECREASED 4 0.0001
126 CHILLS 13 0.0001
127 OROPHARYNGEAL DISCOMFORT 1 0.0001
128 TINNITUS 5 0.0001
129 FEELING COLD 3 0.0001
130 PERSONALITY CHANGE 1 0.0001
131 FLANK PAIN 1 0.0001
132 PROTEINURIA 2 0.0001
133 SINUS DISORDER 2 0.0001
134 UPPER LIMB FRACTURE 2 0.0001
135 TOOTH ABSCESS 1 0.0001
136 BODY TEMPERATURE INCREASED 2 0.0001
137 HELICOBACTER INFECTION 1 0.0001
138 VENTRICULAR EXTRASYSTOLES 1 0.0001
139 TENDERNESS 1 0.0001
140 HIP FRACTURE 3 0.0001
141 PRODUCT DOSE OMISSION ISSUE 27 0.0001
142 WOUND INFECTION 1 0.0001
143 GASTROINTESTINAL PAIN 1 0.0001
144 ANAPHYLACTIC REACTION 5 0.0001
145 VIRAL INFECTION 3 0.0001
146 VENTRICULAR FIBRILLATION 1 0.0001
147 FISTULA 1 0.0001
148 GASTRIC HAEMORRHAGE 1 0.0001
149 POST PROCEDURAL HAEMORRHAGE 1 0.0001
150 ACCIDENT 1 0.0001
151 WRIST FRACTURE 1 0.0001
152 LOCALISED INFECTION 2 0.0001
153 CARDIOMEGALY 1 0.0001
154 INJECTION SITE EXTRAVASATION 1 0.0001
155 SECRETION DISCHARGE 1 0.0001
156 DERMATITIS ALLERGIC 1 0.0001
157 PRODUCT COMPLAINT 2 0.0001
158 CARDIOVASCULAR DISORDER 2 0.0001
159 ORAL CANDIDIASIS 1 0.0001
160 TREATMENT NONCOMPLIANCE 4 0.0001
161 ATRIAL FIBRILLATION 7 0.0001
162 WOUND 2 0.0001
163 SEASONAL ALLERGY 1 0.0001
164 BRONCHOSPASM 1 0.0001
165 NASAL CONGESTION 4 0.0001
166 CARDIOMYOPATHY 1 0.0001
167 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
168 IMMUNODEFICIENCY 1 0.0001
169 GASTROINTESTINAL DISORDER 6 0.0001
170 APHASIA 2 0.0001
171 URTICARIA 11 0.0001
172 DEVICE RELATED INFECTION 1 0.0001
173 LYMPHOMA 1 0.0001
174 ANKLE FRACTURE 1 0.0001
175 RENAL DISORDER 3 0.0001
176 ARRHYTHMIA 3 0.0001
177 PNEUMOTHORAX 1 0.0001
178 BLOOD POTASSIUM INCREASED 1 0.0001
179 BLOOD PRESSURE DECREASED 4 0.0001
180 CHEST PAIN 11 0.0001
181 CIRCULATORY COLLAPSE 1 0.0001
182 CHEST DISCOMFORT 6 0.0001
183 NERVOUSNESS 3 0.0001
184 PARAESTHESIA 9 0.0001
185 HEAD DISCOMFORT 1 0.0001
186 GALLBLADDER DISORDER 1 0.0001
187 OSTEOMYELITIS 1 0.0001
188 RESTLESS LEGS SYNDROME 1 0.0001
189 CONJUNCTIVITIS 1 0.0001
190 EYE SWELLING 2 0.0001
191 CARDIAC DISORDER 5 0.0001
192 HEPATIC CIRRHOSIS 1 0.0001
193 FOOT FRACTURE 1 0.0001
194 POST PROCEDURAL COMPLICATION 1 0.0001
195 PALPITATIONS 6 0.0001
196 SKIN FISSURES 1 0.0001
197 BLOOD PRESSURE ABNORMAL 1 0.0001
198 SPINAL FRACTURE 1 0.0000
199 VERTIGO 3 0.0000
200 FLUSHING 5 0.0000
201 PYREXIA 17 0.0000
202 PRODUCT PREPARATION ERROR 1 0.0000
203 LUNG NEOPLASM MALIGNANT 2 0.0000
204 RIB FRACTURE 1 0.0000
205 ILLNESS 5 0.0000
206 ROAD TRAFFIC ACCIDENT 2 0.0000
207 RENAL IMPAIRMENT 4 0.0000
208 FATIGUE 37 0.0000
209 HYPERHIDROSIS 6 0.0000
210 SKIN CANCER 1 0.0000
211 RHINORRHOEA 3 0.0000
212 MENTAL DISORDER 2 0.0000
213 MELAENA 1 0.0000
214 INFLUENZA 5 0.0000
215 ORAL PAIN 1 0.0000
216 CHROMATURIA 1 0.0000
217 HEART RATE IRREGULAR 1 0.0000
218 ABDOMINAL PAIN UPPER 9 0.0000
219 NASOPHARYNGITIS 8 0.0000
220 OROPHARYNGEAL PAIN 4 0.0000
221 SWELLING 4 0.0000
222 PAIN 26 0.0000
223 CEREBROVASCULAR ACCIDENT 7 0.0000
224 MENTAL IMPAIRMENT 1 0.0000
225 PAIN IN EXTREMITY 12 0.0000
226 SYNCOPE 4 0.0000
227 CELLULITIS 2 0.0000
228 CONDITION AGGRAVATED 12 0.0000
229 PERIPHERAL SWELLING 6 0.0000
230 ERECTILE DYSFUNCTION 1 0.0000
231 OFF LABEL USE 34 0.0000
232 ANAPHYLACTIC SHOCK 1 0.0000
233 UNRESPONSIVE TO STIMULI 1 0.0000
234 GASTRITIS 1 0.0000
235 THROMBOSIS 3 0.0000
236 JAUNDICE 1 0.0000
237 LIMB INJURY 1 0.0000
238 DIVERTICULITIS 1 0.0000
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
240 INTENTIONAL DOSE OMISSION 1 0.0000
241 SEIZURE 4 0.0000
242 ASTHENIA 13 0.0000
243 ABDOMINAL PAIN 8 0.0000
244 DYSSTASIA 1 0.0000
245 COVID-19 6 0.0000
246 DYSPHONIA 2 0.0000
247 BONE PAIN 2 0.0000
248 VOMITING 16 0.0000
249 LABORATORY TEST ABNORMAL 1 0.0000
250 TACHYCARDIA 3 0.0000
251 LACRIMATION INCREASED 1 0.0000
252 NAUSEA 25 0.0000
253 MIGRAINE 3 0.0000
254 CONTUSION 3 0.0000
255 NIGHT SWEATS 1 0.0000
256 SWELLING FACE 2 0.0000
257 IMPAIRED HEALING 1 0.0000
258 STAPHYLOCOCCAL INFECTION 1 0.0000
259 HEART RATE INCREASED 3 0.0000
260 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
261 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
262 COUGH 8 0.0000
263 HYPOXIA 1 0.0000
264 SLEEP DISORDER 2 0.0000
265 LYMPHADENOPATHY 1 0.0000
266 CEREBRAL HAEMORRHAGE 1 0.0000
267 MOBILITY DECREASED 2 0.0000
268 ACCIDENTAL OVERDOSE 1 0.0000
269 SEPSIS 3 0.0000
270 DYSARTHRIA 1 0.0000
271 DYSPNOEA EXERTIONAL 1 0.0000
272 HOT FLUSH 2 0.0000
273 BLOOD PRESSURE INCREASED 4 0.0000
274 PRURITUS 10 0.0000
275 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
276 CARDIAC FAILURE 2 0.0000
277 OEDEMA PERIPHERAL 3 0.0000
278 INFLUENZA LIKE ILLNESS 2 0.0000
279 CARDIAC ARREST 2 0.0000
280 ABDOMINAL DISCOMFORT 4 0.0000
281 HYPOACUSIS 1 0.0000
282 MYOCARDIAL INFARCTION 4 0.0000
283 ANGIOEDEMA 1 0.0000
284 PULMONARY OEDEMA 1 0.0000
285 ADVERSE DRUG REACTION 2 0.0000
286 INCORRECT DOSE ADMINISTERED 5 0.0000
287 SKIN IRRITATION 1 0.0000
288 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
289 WEIGHT DECREASED 6 0.0000
290 OCULAR HYPERAEMIA 1 0.0000
291 PULMONARY EMBOLISM 2 0.0000
292 NEUROPATHY PERIPHERAL 2 0.0000
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
294 DRUG INTOLERANCE 2 0.0000
295 DIZZINESS 10 0.0000
296 LEUKOPENIA 1 0.0000
297 AGGRESSION 1 0.0000
298 FLUID RETENTION 1 0.0000
299 MUSCULOSKELETAL PAIN 1 0.0000
300 SPEECH DISORDER 1 0.0000
301 DEPRESSED MOOD 1 0.0000
302 PNEUMONIA 6 0.0000
303 OEDEMA 1 0.0000
304 TREMOR 3 0.0000
305 ARTHROPATHY 1 0.0000
306 WEIGHT INCREASED 4 0.0000
307 MYALGIA 3 0.0000
308 LETHARGY 1 0.0000
309 EYE IRRITATION 1 0.0000
310 BACK PAIN 4 0.0000
311 DISEASE PROGRESSION 2 0.0000
312 WHEEZING 1 0.0000
313 IRRITABILITY 1 0.0000
314 STOMATITIS 1 0.0000
315 FEELING HOT 1 0.0000
316 RASH 7 0.0000
317 MALAISE 7 0.0000
318 DYSPNOEA 9 0.0000
319 LOSS OF CONSCIOUSNESS 2 0.0000
320 DEEP VEIN THROMBOSIS 1 0.0000
321 DEHYDRATION 2 0.0000
322 DRY SKIN 2 0.0000
323 HYPOTENSION 3 0.0000
324 SOMNOLENCE 3 0.0000
325 ERYTHEMA 3 0.0000
326 ARTHRALGIA 6 0.0000
327 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
328 THERAPY INTERRUPTED 1 0.0000
329 DIARRHOEA 9 0.0000
330 CONSTIPATION 3 0.0000
331 AGITATION 1 0.0000
332 BRONCHITIS 1 0.0000
333 DYSGEUSIA 1 0.0000
334 HALLUCINATION 1 0.0000
335 HEADACHE 8 0.0000
336 PROSTATE CANCER 1 0.0000
337 FALL 4 0.0000
338 URINARY TRACT INFECTION 2 0.0000
339 DEATH 10 0.0000
340 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
341 DEVICE ISSUE 1 0.0000
342 NO ADVERSE EVENT 2 0.0000
343 BREAST CANCER 1 0.0000
344 PRODUCT USE ISSUE 2 0.0000
345 DYSPHAGIA 1 0.0000
346 DYSPEPSIA 1 0.0000
347 SINUSITIS 1 0.0000
348 HAEMOGLOBIN DECREASED 1 0.0000
349 HAEMORRHAGE 1 0.0000
350 HYPERTENSION 2 0.0000
351 ASTHMA 1 0.0000
352 MUSCULAR WEAKNESS 1 0.0000
353 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
354 DECREASED APPETITE 2 0.0000
355 FEELING ABNORMAL 2 0.0000
356 JOINT SWELLING 1 0.0000
357 EMOTIONAL DISTRESS 1 0.0000
358 VISUAL IMPAIRMENT 1 0.0000
359 PRODUCT QUALITY ISSUE 1 0.0000
360 MEMORY IMPAIRMENT 1 0.0000
361 INFECTION 1 0.0000
362 HYPOAESTHESIA 1 0.0000
363 CONFUSIONAL STATE 1 0.0000
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
365 HYPERSENSITIVITY 1 0.0000
366 GAIT DISTURBANCE 1 0.0000
367 ALOPECIA 1 0.0000
368 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
369 DRUG INEFFECTIVE 6 0.0000
370 DEPRESSION 1 0.0000
371 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
372 INSOMNIA 1 0.0000
373 ANXIETY 1 0.0000